2017
DOI: 10.1097/mpa.0000000000000791
|View full text |Cite
|
Sign up to set email alerts
|

Pancreatic Cancer Incidence and Lethality Rates in Brazil

Abstract: Overall increase trends in PC incidence and lethality were observed. Pancreatic cancer remains an urban disease in Brazil, the highest incidence found in the most developed regions as in large metropolitan integrated municipalities. Improvement in diagnosis, notification quality, a rapidly aging population, and a great demographic dynamism could in part explain this fact.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 22 publications
2
13
0
Order By: Relevance
“…Interestingly, other studies had already identified South and Southeast Brazil as regions with higher frequencies of cancer cases (34,35). Similar to recent ecological studies from our group pertaining to gastric cancer (18) and pancreatic cancer (19), the hospitalization rates were higher in the South and Southeast regions, whereas in the North and Northeast regions, the rates were the lowest in the country. Here, the highest rates of EC were observed in areas of greater economic development, which also have a higher HDI and lower social vulnerability indices (SVIs).…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Interestingly, other studies had already identified South and Southeast Brazil as regions with higher frequencies of cancer cases (34,35). Similar to recent ecological studies from our group pertaining to gastric cancer (18) and pancreatic cancer (19), the hospitalization rates were higher in the South and Southeast regions, whereas in the North and Northeast regions, the rates were the lowest in the country. Here, the highest rates of EC were observed in areas of greater economic development, which also have a higher HDI and lower social vulnerability indices (SVIs).…”
Section: Discussionsupporting
confidence: 88%
“…Data source. The study methods have been described in similar previous studies from our group elsewhere (18,19). Data from the Health Informatics Department of the Brazilian Ministry of Health (DATASUS) (http://www2.datasus.gov.…”
Section: Methodsmentioning
confidence: 99%
“…Previous epidemiological studies performed in developed countries have demonstrated a significant increase in the incidence of pancreatic cancer . Similarly, data from government‐sponsored databases in Brazil point to a nearly twofold increase in the incidence of pancreatic cancer over the last decade . While this may stem from improvements in our country’s notification systems, the upward trends in the number of new pancreatic cancer cases seen in our institution ratify the findings of population‐based studies.…”
Section: Discussionsupporting
confidence: 85%
“…Also, they may underestimate the consequences of the disease in the studied populations, even in small countries with organized cancer databases . In Brazil, there is limited information on the epidemiological burden of pancreatic cancer and national cancer databases sponsored by the government suffer from significant problems, such as underreporting of incident cases and deaths . Therefore, other sources of information should be explored to better understand the population of patients treated for pancreatic cancer.…”
Section: Introductionmentioning
confidence: 99%
“…7 The number of hospitalizations due to pancreatic cancer (not the incidence rate) within the Brazilian National Health System doubled from 2005 to 2012 for both sexes, from 2.4/100,000 to 4.5/100,000, with the highest increase in the states of the northeastern region. 8 The importance of this demonstration of the increase in the burden of pancreatic cancer is that there are no detectable risk factors for this neoplasm. 9 People with pancreatic cancer have not benefited from recent improvements in overall survival relating to genetic profiling ("precision medicine"), 10 and no screening tool has been proven to be effective for early diagnosis of pancreatic cancer.…”
mentioning
confidence: 98%